| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |